EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of Plasma Metagenomic Next-generation Sequencing and PCR Methods for Epstein–Barr Virus Viral Load Monitoring in Nasopharyngeal Carcinoma

Harish N Vasudevan, Ann A Lazar, Kevin Reyes, D A Rong, Shaun Arevalo, Scot Federman, Jason W Chan, Charles Y Chiu, Steve Miller, Sue S Yom

Anticancer Research · 2024

DOI: 10.21873/anticanres.17370 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Anticancer Research, 2024. Verfasst von Harish N Vasudevan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of California, San Francisco, CA, U.S.A. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Viral Load, Nasopharyngeal Carcinoma, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Plasma Epstein-Barr virus (EBV) viral load measurement is prognostic in nasopharyngeal carcinoma (NPC) disease monitoring; however, a consensus measurement approach does not exist. This study characterized the clinical performance of metagenomic next-generation sequencing (mNGS), an unbiased sequencing-based assay distinct from polymerase chain reaction (PCR) or targeted sequencing approaches, in 73 peripheral blood specimens from 32 patients diagnosed with NPC. PATIENTS AND METHODS: Samples were analyzed for plasma EBV viral load either by mNGS profiling or PCR-based assays (either LMP2 or BAMHI-W PCR) and compared to tumor presence by clinical assessment. Plasma mNGS-based EBV detection was quantified as reads per million (RPM). RESULTS: Plasma mNGS displayed similar overall performance (100% sensitivity, 86% specificity, 92% accuracy) to BAMHI-W PCR (100% sensitivity, 86% specificity, 94% accuracy) and superior performance to the LMP2 PCR assay (36% sensitivity, 56% specificity, 45% accuracy). In a subset of 13 patients who underwent longitudinal analysis, plasma mNGS EBV RPM correlated with cancer recurrence (95%CI Pre-CRT=232.10±214; 95%CI Post-CRT=0.34±0.32; 95%CI difference=-231.70±214; *p=0.03, paired t-test), suggesting plasma mNGS exhibits potential for monitoring recurrence. CONCLUSION: Plasma mNGS is a distinct method for EBV titer measurement in NPC patients and more broadly, is a promising method for non-invasive monitoring of disease status for infection-associated malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 4, HumanViral LoadNasopharyngeal CarcinomaHigh-Throughput Nucleotide SequencingMetagenomicsEpstein-Barr Virus InfectionsPolymerase Chain ReactionNasopharyngeal NeoplasmsHumansMaleFemaleMiddle AgedAdultAgedDNA, Viral

Stichwörter der Autor:innen

Epstein–Barr virusbiomarkermNGSnasopharyngeal carcinomaplasma viral load

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of California, San Francisco, CA, U.S.A.
  • Division of Oral Epidemiology and Division of Biostatistics, University of California, San Francisco, CA, U.S.A.
  • Department of Laboratory Medicine, University of California, San Francisco, CA, U.S.A.
  • Department of Radiation Oncology, University of California, San Francisco, CA, U.S.A.; Sue.Yom@ucsf.edu.

Zitieren

APA

Vasudevan, H. N., Lazar, A. A., Reyes, K., Rong, D. A., Arevalo, S., Federman, S., Chan, J. W., Chiu, C. Y., Miller, S., & Yom, S. S. (2024). Comparison of Plasma Metagenomic Next-generation Sequencing and PCR Methods for Epstein–Barr Virus Viral Load Monitoring in Nasopharyngeal Carcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17370

Vancouver

Vasudevan HN, Lazar AA, Reyes K, Rong DA, Arevalo S, Federman S, et al. Comparison of Plasma Metagenomic Next-generation Sequencing and PCR Methods for Epstein–Barr Virus Viral Load Monitoring in Nasopharyngeal Carcinoma. Anticancer Research. 2024. doi:10.21873/anticanres.17370

BibTeX
@article{Vasudevan2024,
  author = {Vasudevan, Harish N and Lazar, Ann A and Reyes, Kevin and Rong, D A and Arevalo, Shaun and Federman, Scot and Chan, Jason W and Chiu, Charles Y and Miller, Steve and Yom, Sue S},
  title = {Comparison of Plasma Metagenomic Next-generation Sequencing and PCR Methods for Epstein–Barr Virus Viral Load Monitoring in Nasopharyngeal Carcinoma},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17370}
}
Kostenlos starten →